| 发明名称 |
PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY |
| 摘要 |
This invention relates to the use of pharmaceutical compositions comprising a therapeutically effective combination of Tesofensine and Metoprolol for preventing the cardiovascular side effects of Tesofensine, while leaving the robust inhibitory efficacy on food intake and body weight loss unaffected. |
| 申请公布号 |
US2017007557(A1) |
申请公布日期 |
2017.01.12 |
| 申请号 |
US201615206477 |
申请日期 |
2016.07.11 |
| 申请人 |
SANIONA A/S |
发明人 |
Hansen Henrik Bjork;Grunnet Morten;Hjorth Bo;Hyveled-Nielsen Lars;Lassen Jorgen Buus;Sundgreen Claus |
| 分类号 |
A61K31/138;A61K31/46 |
主分类号 |
A61K31/138 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating type 2 diabetes in a human comprising:
administering Tesofensine, or a pharmaceutically acceptable salt thereof, to the human; in combination with Metoprolol, or a pharmaceutically acceptable salt thereof, wherein the combination is effective in treating the type 2 diabetes and wherein the combination is effective in preventing or alleviating drug-induced cardiovascular side-effects. |
| 地址 |
Ballerup DK |
